You are here

funding

Glycomine grabs $115M series C to fund phase 2 journey for rare genetic disorder drug

Fierce Biotech

Wed, 04/16/25 - 11:34 am

clinical trials

US risks losing biotech edge to China, report warns

BioPharma Dive

Tue, 04/8/25 - 10:56 pm

Third Rock-backed Merida launches with $121M series A to fund autoimmune pipeline

Fierce Biotech

Tue, 04/8/25 - 10:51 pm

Third Rock Ventures

Graves' disease

MoonLake secures $500m for lead drug, plus other financings

Pharmaphorum

Fri, 04/4/25 - 09:45 am

MoonLake Immunotherapeutics

inflammatory diseases

Biotech ‘megarounds’ hold steady as startups, VCs wait on IPOs

BioPharma Dive

Thu, 04/3/25 - 11:18 am

venture capital

AIRNA nets $155M series B to launch clinical test of RNA editing tech

Fierce Biotech

Tue, 04/1/25 - 11:34 am

As Trump Cuts Cancer Research Funding, Billionaire Sean Parker Wants To Scale It Up

Forbes

Mon, 03/31/25 - 10:53 am

Parker Institute for Cancer Immunotherapy

DBV Technologies announces up to $307M financing to advance Viaskin Peanut program

MSN/Seeking Alpha

Fri, 03/28/25 - 11:20 am

DBV Technologies

Character raises $93m for eye drugs, plus other financings

Pharmaphorum

Wed, 03/26/25 - 10:13 am

Character Biosciences

age-related macular degeneration

Ampersand Biotechnologies

European countries, universities implement initiatives to attract US researchers amid 'brutal funding cuts'

Fierce Biotech

Tue, 03/25/25 - 10:23 am

The Netherlands

federal funding

Funding drought: how can biotech and biopharma keep trials running?

Clinical Trials Arena

Thu, 03/20/25 - 11:12 am

clinical trials

Sofinnova’s latest biotech fund sprouts three new startups

BioPharma Dive

Wed, 03/19/25 - 11:24 am

Forth Therapeutics

venture capital

Lilly backs precision medicine start-up’s $65 million raise

Chemical and Engineering News

Wed, 03/19/25 - 11:16 am

Ampersand Biosciences

Flagship Pioneering

How non-traditional investors fuel up-and-coming biotechs when VC funding dries up

Pharma Voice

Tue, 03/18/25 - 11:23 am

Arbor raises $74M amid genetic medicine’s funding slump

BioPharma Dive

Tue, 03/18/25 - 11:03 am

Arbor Technologies

genetic medicine

Primary Hyperoxaluria

Latigo raises $150m for non-opioid painkiller push

Pharmaphorum

Mon, 03/17/25 - 10:06 am

non-opioid pain treatments

Vertex Pharmaceuticals

Biotech Maxion Therapeutics secures $72M Series A

Tech.eu

Mon, 03/17/25 - 10:05 am

Maxion Therapeutics

autoimmune disease

cardiovascular disease

Bluebird’s go-private deal highlights fraught life preserver for struggling biotechs

BioSpace

Wed, 03/12/25 - 11:19 am

Insilico Medicine raises $110M for new trials and robotic helping hands

Fierce Biotech

Wed, 03/12/25 - 11:15 am

artificial intelligence

Trimtech Therapeutics Raises $31M in Seed Funding

FinSMEs

Wed, 03/5/25 - 11:11 pm

Trimtech Therapeutics

targeted protein degradation

Pages